Informatics, Tissue Resource, and Pathology Core

信息学、组织资源和病理学核心

• 批准号: 8728577
• 负责人: JEFFREY E GERSHENWALD
• 金额: $ 15.05万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-07-09 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8728577
• 关键词: Accounting; Address; Advisory Committees; Advocate; Blood; Blood specimen; Budgets; Cancer Center; Clinical; Clinical Trials; Collaborations; Collection; Communication; Consultations; DNA; Data; Development; Doctor of Medicine; Electronics; Evaluation; Funding; Goals; Guidelines; Histologic; Histology; Informatics; Internet; Lesion; Liquid substance; Maintenance; Methodology; Methods; Minority; Molecular Profiling; Monitor; Mutation; Neoplasm Metastasis; Pathologic; Pathology; Patient Care; Patients; Policies; Preparation; Primary Neoplasm; Procedures; Prognostic Factor; Prognostic Marker; Progress Reports; Protein Array; Proteins; Publications; RNA; Regulation; Reporting; Research; Research Personnel; Research Project Grants; Resources; Retrieval; Sampling; Schedule; Site; Skin; Specimen; Specimen Handling; Staging; Teleconferences; Tissue Microarray; Tissue Sample; Tissues; Translating; Translational Research; University of Texas M D Anderson Cancer Center; Woman; base; career development; disorder prevention; flexibility; follow-up; human tissue; improved; lectures; meetings; melanoma; programs; prospective; quality assurance; relational database; repository; research and development; success; symposium; tissue processing; tissue resource; treatment strategy; tumor

The Administrative Planning and Evaluation Core, Core A, is critical to the success of the SPORE. Dr. Elizabeth Grimm is the overall Core Director, and is assisted by three Co-Directors, including the founding Co-Director, Dr. Jeffrey E. Lee, who will chair the Executive Committee meetings which will be composed of all Co-PIs and one leader from each Project and Core. Two new co-directors include Patrick Hwu, M.D., as director of the Clinical Trials Resource which for now will be incorporated as part of Core A; and Jeffrey E. Gershenwald, M.D., as overall director of patient informatics and tumor acquisition and distribution. Our Executive Committee will meet monthly to review scientific progress and fiscal status and will help surmount problems or barriers to assure that all goals are met within a realistic timeframe and within the budget constraints. This Administrative Core will schedule all meetings with investigators and assure optimum communication with investigators at M.D. Anderson Cancer Center and elsewhere. All SPORE investigators will participate in weekly melanoma seminars and regularly report progress to the Internal Advisory Committee. An External Advisory Committee will evaluate status and progress of all SPORE research programs by annual meetings either in Houston or by web/video or teleconference. Specific responsibilities of Core A include * Compliance with all general, governmental and NCI regulations and requirements. * Communication and consultation with the NCI in preparation of all required reports and publications. * Coordination of data control quality assurance issues * Oversight and support for the Informatics, Tissue Resource and Pathology Core B. * Optimization of clinical trial efforts by a Clinical Trials Management Resource in this Core A. * Maintenance of fiscal and budgetary functions, and managing flexibility in funding. * Convene SPORE Administrative meetings, including the Executive Committee, the Internal and External Advisory Committees, weekly scientific meetings, quarterly research meetings, lectures, and symposia. * Administration of the Developmental Research and Career Development Programs. * Coordination and Funding of Patient Advocate activities. * Establishment and monitoring of policies for recruitment of women and minorities of this program. * Coordination with other SPORE sites to promote and maintain communication and integration through sponsoring and/or attending a yearly Skin SPORE conference, and also through sharing and distribution of materials, electronic communications, and evaluation of progress reports.

行政计划和评估核心核心A对于孢子的成功至关重要。伊丽莎白·格里姆（Elizabeth Grimm）博士是整个核心主任，由三个联合主任，包括创始联合主任杰弗里·E·李（Jeffrey E.两个新的联合导演包括医学博士Patrick HWU AS 临床试验资源主任，目前将被纳入核心A的一部分；以及医学博士Jeffrey E. Gershenwald，担任患者信息学和肿瘤的总统总监。我们的执行委员会将每月开会以审查科学进步和财政状况，并将帮助克服问题或障碍，以确保在现实的时间范围内和预算限制内实现所有目标。此行政核心将安排与调查人员的所有会议，并确保最佳 与M.D. Anderson癌症中心以及其他地方的调查人员进行沟通。所有孢子调查人员将参加每周的黑色素瘤研讨会，并定期向内部咨询委员会报告进度。外部咨询委员会将通过休斯顿的年度会议，网络/视频或电话会议评估所有孢子研究计划的状态和进度。具体职责 核心A包括 *遵守所有一般，政府和NCI法规及要求。 *与NCI进行沟通和咨询，以准备所有必需的报告和 出版物。 *数据控制质量保证问题的协调 *监督和支持信息学，组织资源和病理学核心B。 *临床试验管理资源优化临床试验工作 核心A。 *维护财政和预算功能，并管理资金灵活性。 *召集孢子行政会议，包括执行委员会， 内部和外部咨询委员会，每周科学会议，季度 研究会议，讲座和专题讨论会。 *管理发展研究和职业发展计划。 *患者倡导活动的协调和资金。 *制定和监视招募妇女和少数民族的政策 程序。 *通过赞助和/或参加年度皮肤孢子会议，以及分享和分发材料，电子通信以及进度报告的评估，与其他孢子站点协调，以促进和维持沟通和整合。